181696-35-5 (戊地昔布磺酸,Valdecoxib Sulfonic Acid)

4-(5-甲基-3-苯基异恶唑-4-基)苯磺酸;帕瑞昔布杂质25;(1S,2S)-N-BOC-1-氨基-2-苯基环丙羧酸;二苄基二乙基膦氨;伐地考昔杂质D;戊地昔布杂质D;伐地昔布杂质D;戊地昔布磺酸;4-(5-甲基-3-苯基-4-异恶唑基)苯磺酸;中间体有关;代他考昔杂质D;帕瑞昔布钠杂质07;4-(5-甲基-3-苯基-异噁唑基)苯磺酸;戊地昔布磺酸/戊地昔布杂质D;

4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonic acid;2,6-DICHLORO-4-(TRIFLUOROMETHYLOXY)BROMOBEN;VALDECOXIB IMPURITY D;Valdecoxib Sulfonic;Valdecoxib Sulfonic Acid;4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonic acid;2,6-DICHLORO-4-(TRIFLUOROMETHYLOXY)BROMOBENZENE;Valdecoxib IMpurity-D (Valdecoxib SulfonicAcid);4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonic Acid;Benzenesulfonic acid, 4-(5-Methyl-3-phenyl-4-isoxazolyl)-;3-Phenyl-4-(4-aMinosulfonylbenzyl)-5-Methylisoxazole ,Valdecoxib Sulfonyl Chloride ,valdecoxib iMpurity D;AK133366;BCP23915;BC600175;AX8254917;4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)b;

MFCD26743607

LLWOSCPRJRUVST-UHFFFAOYSA-N

1S/C16H13NO4S/c1-11-15(12-7-9-14(10-8-12)22(18,19)20)16(17-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H,18,19,20)

S(C1C=CC(=CC=1)C1=C(C)ON=C1C1C=CC=CC=1)(=O)(=O)O

2934999090

M191686